Loomis, Sayles & Company Portfolio holdings
AUM
$79.8B
1-Year Return
31.99%
This Quarter Return
-0.56%
1 Year Return
+31.99%
3 Year Return
+166.63%
5 Year Return
+219.21%
10 Year Return
+619.03%
AUM
$81.3B
AUM Growth
-$1.18B
(-1.4%)
Cap. Flow
+$173M
Cap. Flow
% of AUM
0.21%
Top 10 Holdings %
Top 10 Hldgs %
39.76%
Holding
963
New
137
Increased
344
Reduced
325
Closed
77
Top Buys
| 1 |
Vertex Pharmaceuticals
VRTX
|
$899M |
| 2 |
Salesforce
CRM
|
$407M |
| 3 |
Alibaba
BABA
|
$150M |
| 4 |
Cummins
CMI
|
$120M |
| 5 |
T-Mobile US
TMUS
|
$76.8M |
Top Sells
| 1 |
Deere & Co
DE
|
$695M |
| 2 |
Expeditors International
EXPD
|
$202M |
| 3 |
CERN
Cerner Corp
CERN
|
$163M |
| 4 |
PRAH
PRA Health Sciences, Inc.
PRAH
|
$116M |
| 5 |
M&T Bank
MTB
|
$113M |
Sector Composition
| 1 | Technology | 27.81% |
| 2 | Consumer Discretionary | 14.99% |
| 3 | Communication Services | 14.19% |
| 4 | Healthcare | 13.76% |
| 5 | Industrials | 10.25% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
201
Lakeland Financial Corp
LKFN
$1.73B
| $38.3M | 0.05% |
537,449
+109,287
| +26% | +$7.79M |
|
|
BWIN
202
Baldwin Insurance Group
BWIN
$2.27B
| $37.8M | 0.05% |
+1,136,635
| New | +$37.8M |
|
|
PRFT
203
DELISTED
Perficient Inc
PRFT
| $37.7M | 0.05% |
325,885
-4,858
| -1% | -$562K |
|
204
Morningstar
MORN
$10.8B
| $37.5M | 0.05% |
144,959
+4,039
| +3% | +$1.05M |
|
|
HZNP
205
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $37.5M | 0.05% |
341,965
+9,730
| +3% | +$1.07M |
|
206
Nova
NVMI
$7.58B
| $36.9M | 0.05% |
360,495
+10,032
| +3% | +$1.03M |
|
207
Bio-Techne
TECH
$8.46B
| $36.9M | 0.05% |
304,328
-87,500
| -22% | -$10.6M |
|
208
Nomad Foods
NOMD
$2.21B
| $36.7M | 0.05% |
1,333,419
-20,444
| -2% | -$563K |
|
|
WLL
209
DELISTED
Whiting Petroleum Corporation
WLL
| $36.6M | 0.05% |
626,433
-291,259
| -32% | -$17M |
|
210
nLIGHT
LASR
$1.44B
| $36.2M | 0.04% |
1,285,434
-19,943
| -2% | -$562K |
|
211
Oxford Industries
OXM
$629M
| $35.8M | 0.04% |
397,046
+36,945
| +10% | +$3.33M |
|
212
BioMarin Pharmaceuticals
BMRN
$11.1B
| $35.8M | 0.04% |
462,757
+2,684
| +0.6% | +$207K |
|
|
SWTX
213
DELISTED
SpringWorks Therapeutics
SWTX
| $35.3M | 0.04% |
556,940
-8,638
| -2% | -$548K |
|
214
MKS Inc. Common Stock
MKSI
$7.02B
| $35.3M | 0.04% |
234,122
-60,793
| -21% | -$9.17M |
|
|
AVLR
215
DELISTED
Avalara, Inc.
AVLR
| $35.2M | 0.04% |
201,281
+14,083
| +8% | +$2.46M |
|
216
Trimble
TRMB
$19.2B
| $35M | 0.04% |
425,485
+12,126
| +3% | +$997K |
|
217
Ranpak Holdings
PACK
$435M
| $35M | 0.04% |
+1,304,763
| New | +$35M |
|
218
e.l.f. Beauty
ELF
$7.6B
| $34.2M | 0.04% |
+1,178,734
| New | +$34.2M |
|
219
Insmed
INSM
$30.7B
| $34M | 0.04% |
1,234,661
+459,411
| +59% | +$12.7M |
|
220
Broadridge
BR
$29.4B
| $34M | 0.04% |
203,907
+5,678
| +3% | +$946K |
|
221
Calix
CALX
$3.96B
| $33.8M | 0.04% |
+684,781
| New | +$33.8M |
|
222
Replimune Group
REPL
$494M
| $33.7M | 0.04% |
1,136,066
+143,473
| +14% | +$4.25M |
|
223
Valvoline
VVV
$4.96B
| $33.6M | 0.04% |
1,077,916
-5,441
| -0.5% | -$170K |
|
224
Bristol-Myers Squibb
BMY
$96B
| $33.5M | 0.04% |
566,230
-1,310,346
| -70% | -$77.5M |
|
225
Charles River Laboratories
CRL
$8.07B
| $33.1M | 0.04% |
80,223
-37,702
| -32% | -$15.6M |
|